Merck KGaA (MRK) Given a 106.00 Price Target by Deutsche Bank AG Analysts
The brokerage presently has a "neutral" rating on the healthcare company's stock. A number of other research analysts have also recently weighed in on MRK.
from Biotech News
The brokerage presently has a "neutral" rating on the healthcare company's stock. A number of other research analysts have also recently weighed in on MRK.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments